Table 2.
Analyte | Nominal Concentration (ng/mL) | Within-Run (n = 5) | Between-Run (n = 15) | ||||
---|---|---|---|---|---|---|---|
Mean Concentration (ng/mL) | CV% | Acc% | Mean Concentration (ng/mL) | CV% | Acc% | ||
rucaparib | 100 | 87 | 6 | 87 | 96 | 8 | 96 |
255 | 250 | 7 | 98 | 259 | 7 | 101 | |
1700 | 1708 | 7 | 100 | 1732 | 4 | 102 | |
4250 | 4190 | 5 | 99 | 4289 | 4 | 101 | |
niraparib | 60 | 61 | 2 | 101 | 60 | 3 | 101 |
153 | 155 | 5 | 101 | 156 | 3 | 102 | |
1020 | 1043 | 2 | 102 | 1044 | 2 | 102 | |
2460 | 2442 | 2 | 96 | 2460 | 3 | 96 | |
olaparib | 140 | 139 | 3 | 99 | 143 | 4 | 102 |
357 | 356 | 2 | 100 | 358 | 3 | 100 | |
2380 | 2361 | 3 | 99 | 2386 | 3 | 100 | |
5950 | 5802 | 3 | 98 | 5810 | 3 | 98 |
Acc%, percentage of accuracy; CV%, coefficient of variation; n, number of replicates.